Ouvrir de nouvelles voies pour développer des solutions et innovations thérapeutiques au service des patients. Parce que la santé a besoin d’audace." title="" class="btn" data-container="body" data-html="true" data-id="34273" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="MSD France"> 6,436 1,029 3,367 7,354 2,344 225,624 1,066,227 24,844 34,417
Sectors
Location
90 E Scott Ave, Rahway, NJ 07065, USA
Rahway
United States of America
Engaged entities
2149Added in Motherbase
29 Apr 2019, 3:39 p.m.At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.
MSD | Home
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | ADLIN Science Biotechnology Research, it services | Other 23 Mar 2025 | | |
![]() | Epitopea biotech, deeptech | Other 31 Jan 2025 | | |
![]() | Hôpital Privé des Côtes d'Armor healthtech | Other 20 Mar 2025 | | |
![]() | P4 Precision Medicine Accelerator Hospitals and Health Care | Other 31 Dec 2024 | | |
![]() | Biosency Medical Equipment Manufacturing, healthtech, deeptech, manufacturing | Other 21 Mar 2025 | | |
![]() | MedEngine Business Consulting and Services, biotech, deeptech | Other 19 Feb 2025 | | |
![]() | Pearce IP legaltech, deeptech | Other 3 Mar 2025 | | |
![]() | Microbiotica Biotechnology Research, biotech, deeptech | Other 26 Feb 2025 | | |
![]() | Optibrium Biotechnology Research, biotech, deeptech | Other 11 Nov 2020 22 Feb 2025 | | |
![]() | CRCI2NA biotech, deeptech | Other 20 Feb 2025 | |
Bij MSD verwelkomen we twee keer per jaar tientallen stagiaires die een belangrijke bijdrage leveren aan ons werk. Momenteel hebben we nog enkele plekken beschikbaar voor gemotiveerden studenten die hun talenten willen inzetten in een professionele, uitdagende omgeving.
HBO/WO-stages
-Onderzoek in Animal & Veterinary Science (Global Clinical Research)
-Life Science-projecten (Global Clinical Trial Operations)
-Data Science & Supply Chain Quality (D&L Quality)
MBO-stages
-Haarlem: Chemie en Analist op de Quality Control-afdeling
-Boxmeer: Biologie, Juridisch Administratief, of Technisch Tekenen
-De Bilt: Juridisch Administratief op de Quality Assurance-afdeling
De meeste stages starten in februari, met enkele mogelijkheden in maart.
Bekijk alle beschikbare stages op www.msdstudent.nl en ontdek hoe je jouw carrière kunt kickstarten bij MSD!
#MSD #Stage #HBO #WO #MBO #Carrièrestart #Innovatie
We are thrilled to re-launch 'The Steward' podcast series which focuses on antimicrobial stewardship and infection control. In this episode, we spotlight health inequalities and their impact on antimicrobial resistance. Join us as we delve into critical aspects of antimicrobial resistance with leading expert Professor Diane Ashiru-Oredope and Dr Sanjay Patel! Stay tuned for in-depth discussions and valuable insights on this pressing public health issue.
https://bit.ly/42gT8oG
Working with partners to bring new and life-changing innovations to patients 🤝
Our business development team is focused on identifying breakthrough science to help make a difference for patients. Hear more about our approach to collaborations https://bit.ly/3PE2RxG #JPM2025
Our business development team is focused on identifying breakthrough science to help make a difference for patients. Hear more about our approach to collaborations. #JPM25
MSD takes time to recognise Less Survivable Cancers, which include lung, liver, brain, oesophageal and pancreatic cancer. Patients with these cancers often face significant challenges, including late-stage diagnosis and limited treatment options. Collectively, these cancers have a 16% average of surviving over five years and represent over 40% of all deaths from cancer in the UK. By shedding light on the unique struggles these patients and their families face, we can work to close the gaps in care and support conversations.
MSD have partnered with Roy Castle Lung Cancer Foundation to create a booklet titled ‘How can I support my loved one with Lung Cancer?’. This booklet is specifically designed for carers of individuals with lung cancer, offering support and essential information about this less survivable cancer https://bit.ly/4fW1SUv
We are committed to taking tangible steps to address health inequity within cancer care. Watch this video of Lorraine Dallas, Director of Prevention, Information & Support at Roy Castle Lung Cancer Foundation, as she discusses the importance of talking about lung cancer, supporting carers and enhancing access to lung cancer care!
Job code: GB-NON-10722 | Date of Preparation: January 2025